Wells Fargo
IRWD icon

Wells Fargo’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wells Fargo’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-47,282
Closed -$58K – 6438
2017
Q3 		$58K Buy
+47,282
New +$651K ﹤0.01% 5416

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wells Fargo's IRWD Position: Q1 2026 in Review

Wells Fargo reduced its Ironwood Pharmaceuticals (IRWD) stake by 67% in Q1 2026, selling an estimated $483K and leaving 58,850 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #4686.

Wells Fargo first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q3 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Wells Fargo held 58,850 shares of Ironwood Pharmaceuticals worth $207K as of Q1 2026.
  • Wells Fargo sold 117,732 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $483K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4686 holding.
  • Wells Fargo first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Ironwood Pharmaceuticals position peaked at $16.9M in Q3 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.